Tapan Chowdhury, the managing director of Square Pharmaceuticals, has announced plans to buy twenty lakh shares of the company, a move that shows strong faith in the business and could reassure other investors. The purchase will be made through the Dhaka Stock Exchange, in public trades or as a block, and will be completed within thirty working days at the market price. When the company filed the disclosure, the share price was near one hundred ninety nine taka and fifty paisa per share, which makes the proposed purchase worth about forty crore taka at that level. Analysts and market watchers view insider buying by a senior executive as a positive sign because it signals that top management believes in the company’s future earnings and core plans. Such a step often calms small shareholders and can steady a stock by showing that those who know the firm best are prepared to put their own money where they see value. Visible support from a leader can help both retail and institutional investors feel more secure, and it can reduce short term selling pressure when markets turn choppy. The purchase may also underline the management’s confidence in steady cash flow, product strength, or planned growth steps that executives prefer to back with personal investment. Buying in the public market would raise day to day demand and show visible interest to other traders, while a block trade would move a large lot in one deal and quickly change ownership patterns. Either route requires clear disclosure and fair handling so all market participants can see the change and understand the reasons behind it. Investors who watch such deals often look for follow up signals from the company, like fresh profit guidance, investment projects, or dividend moves that match the message of personal buying. Regulators and the exchange set the rules for these transactions, and timely announcements help keep trading transparent and fair for small savers. Company leaders and experts note that when top managers buy shares, their personal finances become linked to company outcomes and that alignment can be reassuring for long term holders. For many small investors, this news can be a nudge to review holdings and check that their goals match company prospects. While insider buying is not a guarantee of gains, it is one useful sign among many that helps people form a balanced view of a stock. In the coming weeks, investors and advisers will watch trading volume and any further company statements to judge how the purchase changes market sentiment, and the announced buy may help steady confidence and long-term investor trust.
Tapan Chowdhury’s Tk40cr buyback bet boosts confidence in Square Pharma
2
